H
Hina Zaidi
Researcher at North Shore University Hospital
Publications - 2
Citations - 93
Hina Zaidi is an academic researcher from North Shore University Hospital. The author has contributed to research in topics: Cancer & Nephrotoxicity. The author has an hindex of 2, co-authored 2 publications receiving 67 citations.
Papers
More filters
Journal ArticleDOI
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.
Jordan E. Axelrad,Jordan E. Axelrad,Oren Bernheim,Jean-Frederic Colombel,Stefano Malerba,Ashwin N. Ananthakrishnan,Vijay Yajnik,Gila Hoffman,Manasi Agrawal,Dana J. Lukin,Amit P. Desai,Elisa McEachern,Brian P. Bosworth,Ellen Scherl,Andre Reyes,Hina Zaidi,Prashant Mudireddy,David Dicaprio,Keith Sultan,Burton I. Korelitz,Erwin Wang,Renee Williams,LeaAnn Chen,Seymour Katz,Steven H. Itzkowitz +24 more
TL;DR: In patients with IBD and a history of cancer, exposure to an anti-TNF agent or an antimetabolite after cancer was not associated with an increased risk of incident cancer, compared with patients who did not receive immunosuppression.
Journal ArticleDOI
Sa1138 Patients With Inflammatory Bowel Disease and a History of Cancer: The Risk of Cancer Following Exposure to Immunosuppression
Jordan E. Axelrad,Oren Bernheim,Jean-Frederic Colombel,Stefano Malerba,Ashwin N. Ananthakrishnan,Vijay Yajnik,Gila Hoffman,Manasi Agrawal,Dana J. Lukin,Amit P. Desai,Elisa McEachern,Brian P. Bosworth,Ellen Scherl,Andre Reyes,Hina Zaidi,Prashant Mudireddy,David Dicaprio,Keith Sultan,Burton I. Korelitz,Erwin Wang,Renee Williams,Lea Ann Chen,Seymour Katz,Steven H. Itzkowitz +23 more
TL;DR: Oral TAC therapy appears to be effective for patients with refractory UC, but renal function impairment was frequently observed during this treatment, and careful monitoring of renal function must be required to avoid irreversible chronic renal damage during long-term administration of TAC.